These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21935898)

  • 41. Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses.
    Wrensch F; Karsten CB; Gnirß K; Hoffmann M; Lu K; Takada A; Winkler M; Simmons G; Pöhlmann S
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S210-8. PubMed ID: 26034199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy.
    Porotto M; Orefice G; Yokoyama CC; Mungall BA; Realubit R; Sganga ML; Aljofan M; Whitt M; Glickman F; Moscona A
    J Virol; 2009 May; 83(10):5148-55. PubMed ID: 19264786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features.
    Moeschler S; Locher S; Zimmer G
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29874821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin.
    Usami K; Matsuno K; Igarashi M; Denda-Nagai K; Takada A; Irimura T
    Biochem Biophys Res Commun; 2011 Apr; 407(1):74-8. PubMed ID: 21362405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.
    Kumar M; Bradow BP; Zimmerberg J
    Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishment of pseudovirus infection mouse models for
    Chen Q; Tang K; Zhang X; Chen P; Guo Y
    Acta Pharm Sin B; 2018 Mar; 8(2):200-208. PubMed ID: 29719780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic screening of viral entry inhibitors using surface plasmon resonance.
    Kumar PKR
    Rev Med Virol; 2017 Nov; 27(6):. PubMed ID: 29047180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of Marburg virus glycoprotein in viral entry.
    Manicassamy B; Wang J; Rumschlag E; Tymen S; Volchkova V; Volchkov V; Rong L
    Virology; 2007 Feb; 358(1):79-88. PubMed ID: 16989883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene transfer in human skin with different pseudotyped HIV-based vectors.
    Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
    Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive analysis of ebola virus GP1 in viral entry.
    Manicassamy B; Wang J; Jiang H; Rong L
    J Virol; 2005 Apr; 79(8):4793-805. PubMed ID: 15795265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transduction of the choroid plexus and ependyma in neonatal mouse brain by vesicular stomatitis virus glycoprotein-pseudotyped lentivirus and adeno-associated virus type 5 vectors.
    Watson DJ; Passini MA; Wolfe JH
    Hum Gene Ther; 2005 Jan; 16(1):49-56. PubMed ID: 15703488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vesicular stomatitis virus glycoprotein- and Venezuelan equine encephalitis virus-derived glycoprotein-pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors.
    Lipinski DM; Barnard AR; Charbel Issa P; Singh MS; De Silva SR; Trabalza A; Eleftheriadou I; Ellison SM; Mazarakis ND; MacLaren RE
    Hum Gene Ther; 2014 Jan; 25(1):50-62. PubMed ID: 24125177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-natural amino acid peptide microarrays to discover Ebola virus glycoprotein ligands.
    Rabinowitz JA; Lainson JC; Johnston SA; Diehnelt CW
    Chem Commun (Camb); 2018 Feb; 54(12):1417-1420. PubMed ID: 29297911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses.
    Mudhasani R; Kota KP; Retterer C; Tran JP; Tritsch SR; Zamani R; Whitehouse CA; Bavari S
    J Biomol Screen; 2015 Jan; 20(1):141-52. PubMed ID: 25342145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production.
    Sharkey CM; North CL; Kuhn RJ; Sanders DA
    J Virol; 2001 Mar; 75(6):2653-9. PubMed ID: 11222688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Novel Antiviral Compounds Targeting Entry of Hantaviruses.
    Mayor J; Torriani G; Engler O; Rothenberger S
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33923413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of phosphatidylserine receptors in enveloped virus infection.
    Morizono K; Chen IS
    J Virol; 2014 Apr; 88(8):4275-90. PubMed ID: 24478428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Envelope proteins as antiviral drug target.
    Verma J; Subbarao N; Rajala MS
    J Drug Target; 2020 Dec; 28(10):1046-1052. PubMed ID: 32643453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of heparan sulfate in entry and exit of Ross River virus glycoprotein-pseudotyped retroviral vectors.
    Kesari AS; Sharkey CM; Sanders DA
    Virology; 2019 Mar; 529():177-185. PubMed ID: 30716579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.